| | ATP1A1, ATP1A1-AS1 (G599R +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | ATP1A1, ATP1A1-AS1 (R482K +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | |
| | ATP1A1, ATP1A1-AS1 (E1003K +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD +1 more | |
| | ATP1A1, ATP1A1-AS1 (A566T +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | ATP1A1, ATP1A1-AS1 (T955I +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | ATP1A1, ATP1A1-AS1 (P569R +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | ATP1A1, ATP1A1-AS1 (G518R +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hypomagnesemia, seizures, and intellectual disability 2 +2 more | |
| | | Single nucleotide variant (synonymous variant) | ATP1A1-related disorder +3 more | |
| | | Single nucleotide variant (intron variant) | Hypomagnesemia, seizures, and intellectual disability 2 +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Deletion (intron variant) | Hypomagnesemia, seizures, and intellectual disability 2 +2 more | |
| | | Single nucleotide variant (synonymous variant) | Hypomagnesemia, seizures, and intellectual disability 2 +3 more | |
| | | Single nucleotide variant (intron variant) | Charcot-marie-tooth disease, axonal, type 2DD +2 more | |
| | | Single nucleotide variant (synonymous variant) | Charcot-marie-tooth disease, axonal, type 2DD +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | |
| | | Single nucleotide variant (intron variant) | Hypomagnesemia, seizures, and intellectual disability 2 +2 more | |
| | | Single nucleotide variant (intron variant) | Hypomagnesemia, seizures, and intellectual disability 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | ATP1A1, ATP1A1-AS1 (L813P +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD +1 more | |
| | ATP1A1-AS1, ATP1A1 (C906fs +1 more) | Deletion (frameshift variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | | Single nucleotide variant (synonymous variant) | Hypomagnesemia, seizures, and intellectual disability 2 +2 more | |
| | ATP1A1, ATP1A1-AS1 (D811A +1 more) | Single nucleotide variant (missense variant +1 more) | Charcot-marie-tooth disease, axonal, type 2DD +1 more | GConflicting classifications of pathogenicity |
| | ATP1A1, ATP1A1-AS1 (I592T +1 more) | Single nucleotide variant (missense variant) | not provided +1 more | GPathogenic/Likely pathogenic |
| | ATP1A1, ATP1A1-AS1 (P600T +1 more) | Single nucleotide variant (missense variant) | not provided | |
| | ATP1A1, ATP1A1-AS1 (P600A +1 more) | Single nucleotide variant (missense variant) | Charcot-marie-tooth disease, axonal, type 2DD | |
| | | Single nucleotide variant (missense variant) | not provided | |